Roberto Giovannoni
Has grant
Associate Professor
Research Interests
Explore related searches
Contact this professor
About
Roberto Giovannoni is an Associate Professor at Università degli Studi di Pisa, Italy. His research focuses on various areas including the modulation of tumor cells in pancreatic and breast cancer, nanocarrier systems for pharmaceutical delivery, and the effects of thermal processing on the nutritional properties of fruits and vegetables. He also investigates innovative therapeutic approaches against cancer immunotherapy resistance and lipid metabolism in NAFLD.
Recent Grants
Grant: Close
Oral delivery of Apolipoprotein A-I (Milano variant) as a treatment to prevent the NAFLD progression to NASH and HCC
Open Date: 2023-11-01
Close Date: 2025-10-01
Grant: Close
Orally delivered APOA-IMilano via gene-edited rice for NASH treatment
Open Date: 2023-10-01
Close Date: 2025-09-01
Grant: Open
AI and Health
Open Date: 2022-12-01
Close Date: 2026-11-01
Articles (16)
Endothelial Effects of Simultaneous Expression of Human HO-1, E5NT, and ENTPD1 in a Mouse
The vascular endothelium is key target for immune and thrombotic responses that has to be controlled in successful xenotransplantation. Several genes were identified that, if induced or overexpressed, help to regulate the inflammatory response and preserve the transplanted organ function and metabolism. However, few studies addressed combined expression of such genes. The aim of this work was to evaluate in vivo the effects of the simultaneous expression of three human genes in a mouse generated using the multi-cistronic F2A technology. Male 3-month-old mice that express human heme oxygenase 1 (hHO-1), ecto-5′-nucleotidase (hE5NT), and ecto-nucleoside triphosphate diphosphohydrolase 1 (hENTPD1) (Transgenic) were compared to wild-type FVB mice (Control). Background analysis include extracellular nucleotide catabolism enzymes profile on the aortic surface, blood nucleotide concentration, and serum L-arginine metabolites. Furthermore, inflammatory stress induced by LPS in transgenic and control mice was used to characterize interleukin 6 (IL-6) and adhesion molecules endothelium permeability responses. Transgenic mice had significantly higher rates of extracellular adenosine triphosphate and adenosine monophosphate hydrolysis on the aortic surface in comparison to control. Increased levels of blood AMP and adenosine were also noticed in transgenics. Moreover, transgenic animals demonstrated the decrease in serum monomethyl-L-arginine level and a higher L-arginine/monomethyl-L-arginine ratio. Importantly, significantly decreased serum IL-6, and adhesion molecule levels were observed in transgenic mice in comparison to control after LPS treatment. Furthermore, reduced endothelial permeability in the LPS-treated transgenic mice was noted as compared to LPS-treated control. The human enzymes (hHO-1, hE5NT, hENTPD1) simultaneously encoded in transgenic mice demonstrated benefits in several biochemical and functional aspects of endothelium. This is consistent in use of this approach in the context of xenotransplantation.
Year:
2023
Collaborators (11)
Michela Pozzobon
Assistant Professor (RTdB)
University of Padua
Ewa Slominska
Professor
Medical University of Gdansk
Magdalena Zabielska-Kaczorowska
Assistant professor
Medical University of Gdansk
Ciro De Luca
University of Campania “Luigi Vanvitelli”
Barbara Kutryb-Zajac
Adiunkt/ Assistant professor
Medical University of Gdansk
Assunta Virtuoso
-
Donatella Barisani
University of Milano-Bicocca
Michele Papa
Professore Ordinario
Università degli Studi della Campania Luigi Vanvitelli
Alma Martelli
University of Pisa
Marialuisa Lavitrano
Full Professor
University of Milano-Bicocca
Ryszard T. Smolenski
Medical University of Gdansk

How do I reach out?
Sign in for free to see their profile details and contact information.